Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash flows from operating activities
Net loss	$ (2,980,311)	$ (2,272,572)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	5,038	883
Amortization	212,406	212,406
Stock-based compensation - employees	347,200
Stock-based compensation - others	77,500
Non-cash interest expense	1,170,577	962,526
Non-cash interest expense – related parties	209,576	161,971
Deferred lease expense	27,152	27,151
Foreign exchange (gain) loss	(53,598)	44,143
Changes in operating assets and liabilities which provided (used) cash:
Other receivables	(242,558)	(25,081)
Accounts payable	62,580	(128,185)
Accrued expenses	44,103	278,694
Net cash used in operating activities	(1,120,335)	(738,064)
Cash flows from investing activities
Advance on business acquisition		(250,000)
Leasehold improvements in progress	(5,439)	(102,645)
Net cash used in investing activities	(5,439)	(352,645)
Cash flows from financing activities
Issuance of loans payable	380,000
Repayment of loans payable	(230,000)
Issuance of loans payable - related parties	225,000
Issuance of convertible notes	707,800
Repayment of convertible notes	(20,000)
Issuance of convertible notes - related parties		1,199,963
Net cash provided by financing activities	1,062,800	1,199,963
Net (decrease) increase in cash and cash equivalents	(62,974)	109,254
Cash and cash equivalents, beginning of period	84,978	62,381
Cash and cash equivalents, end of period	22,004	171,635
Supplemental cash flows disclosures
Cash paid for interest	32,598	33,714
Non-cash transactions - investing and financing activities
Patent acquisition liability modification	4,380,000
Conversion of rents due to convertible loan		244,362
Accrued expense converted to convertible loans		$ 831,628